Biohaven Ltd. 8-K

What Happened
Biohaven Ltd. (BHVN) filed a Form 8-K on January 12, 2026 to disclose that it will be making an investor presentation. A copy of the presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference into the report. The company states the information is being furnished under Regulation FD and is not “filed” for purposes of Section 18 of the Exchange Act.

Key Details

• Filing date: January 12, 2026; signed by Matthew Buten, Chief Financial Officer.
• Exhibit attached: Investor Presentation dated January 2026 (Exhibit 99.1).
• Disclosure status: Information furnished under Regulation FD — explicitly “not filed” under Section 18 and not incorporated by reference into other SEC filings except by specific reference.
• Purpose: Public distribution of an investor presentation (no additional financial results or executive changes disclosed in this 8-K).

Why It Matters
This 8-K notifies investors that Biohaven is publicly sharing an investor presentation that may contain business updates or strategic information. Because the presentation is furnished under Regulation FD (and not “filed”), investors should review Exhibit 99.1 directly for any material details they would consider in investment decisions.